chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: VARZOS
Symptoms: Injection site erythema
Clinical narrative: redness of the skin between the injection location and my armpit; This non-serious case was reported by a consumer and described the occurrence of erythema of extremities in a 51-year-old male patient who received Herpes zoster (Shingrix) (batch number X5T42, expiry date 30-JAN-2027) and (batch number 7LC49) for prophylaxis.   Concurrent medical conditions included hypertension and back pain. Concomitant products included gabapentin, losartan and meloxicam.   On 14-FEB-2025, the patient received the 2nd dose of Shingrix .5 ml. On 16-FEB-2025, 2 days after receiving Shingrix, the patient experienced erythema of extremities (Verbatim: redness of the skin between the injection location and my armpit). The outcome of the erythema of extremities was not resolved.   It was unknown if the reporter considered the erythema of extremities to be related to Shingrix.     It was unknown if the company considered the erythema of extremities to be related to Shingrix.   Additional Information: GSK Receipt Date 17-FEB-2025 The patient received Shingrix and on the day of reporting noticed some redness of the skin between the injection location and his armpit (redness).
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Suspected vaccination failure; shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: shingles). The outcome of the vaccination failure and shingles were not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     The company considered the vaccination failure to be unrelated to Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 17-FEB-2025 This case was reported by a patient via interactive digital media. Consumer reported that he/she had the vaccine and just got shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of disease) is considered unrelated to GSK Shingles vaccine.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Eye inflammation, Lacrimation increased, Ocular hyperaemia
Clinical narrative: Bilateral eye inflammation; Bilateral eye tearing; Bilateral eye redness; This non-serious case was reported by a consumer via call center representative and described the occurrence of eye inflammation in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included eye operation (had 23 eye surgeries in his lifetime due to a problem with his eyes since birth).   On 24-AUG-2024, the patient received the 1st dose of Shingrix (intramuscular, right deltoid). In SEP-2024, 5 weeks after receiving Shingrix, the patient experienced eye inflammation (Verbatim: Bilateral eye inflammation), eyes tearing (Verbatim: Bilateral eye tearing) and eye redness (Verbatim: Bilateral eye redness). The outcome of the eye inflammation, eyes tearing and eye redness were not resolved.   It was unknown if the reporter considered the eye inflammation, eyes tearing and eye redness to be related to Shingrix.     It was unknown if the company considered the eye inflammation, eyes tearing and eye redness to be related to Shingrix.   Additional Information: GSK Receipt Date: 24-JAN-2025 The reporter was the patient who had received his first dose of Shingrix on 24th August 2024 and 5 weeks later had developed bilateral eye redness, tearing, and inflammation symptoms that had not resolved.  The patient stated he had been to the ophthalmologist 6 times since having the vaccine.  The patient also told that he had 23 eye surgeries in his lifetime due to a problem with his eyes since birth.
Age: 1.25
Sex: F
Vaccine: HIBV, MMR, PNC20, UNK
Symptoms: Crying, Discomfort, Injection site rash, Malaise, Pyrexia
Clinical narrative: 2 weeks after vaccine, she developed a round, raised rash on either side of her thighs with a fever where the injection site was of her vaccines. She clearly is uncomfortable and crying from not feeling good.
Age: 1.25
Sex: F
Vaccine: HIBV, MMR, PNC20, UNK
Symptoms: Rash papular
Clinical narrative: 2 weeks after vaccine, she developed a round, raised rash on either side of her thighs with a fever where the injection site was of her vaccines. She clearly is uncomfortable and crying from not feeling good.
Age: 73.0
Sex: F
Vaccine: UNK
Symptoms: Asthenia, Injection site swelling, Nausea, Skin reaction, Somnolence
Clinical narrative: Slight swelling at injection sight Large red area size of an orange Nausea for 2 days Lack of energy and sleepy for 7 days
Age: 13.0
Sex: M
Vaccine: DTAP, DTAP
Symptoms: Inappropriate schedule of product administration, Wrong product administered
Clinical narrative: Infanrix dose was given unintendedly to a patient who was supposed to receive a Tdap vaccine; Infanrix dose 3rd given on 15-JAN-2025 and Dtap 2nd dose on 15th October 2011; 13 years patient received Infanrix vaccine; has 2 previous doses of Dtap (September 14, 2011 and October 15, 2011); This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 13-year-old male patient who received DTPa (Infanrix) (batch number 9R2D7, expiry date 23-MAY-2025) for prophylaxis.   Co-suspect products included DTPa (Reduced antigen) (Tdap Vaccine) for prophylaxis and DTPa (DTaP vaccine) for prophylaxis.   Concomitant products included Diphtheria vaccine toxoid, Pertussis vaccine acellular, Tetanus vaccine toxoid (DTaP vaccine).   On 15-JAN-2025, the patient received the 3rd dose of Infanrix. On an unknown date, the patient received Tdap Vaccine. On 15-OCT-2011, the patient received the 2nd dose of DTaP vaccine. On 15-OCT-2011, not applicable after receiving Infanrix and Tdap Vaccine and an unknown time after receiving DTaP vaccine, the patient experienced drug dose administration interval too short (Verbatim: has 2 previous doses of Dtap (September 14, 2011 and October 15, 2011)). On 15-JAN-2025, the patient experienced wrong vaccine administered (Verbatim: Infanrix dose was given unintendedly to a patient who was supposed to receive a Tdap vaccine), drug dose administration interval too long (Verbatim: Infanrix dose 3rd given on 15-JAN-2025 and Dtap 2nd dose on 15th October 2011) and inappropriate age at vaccine administration (Verbatim: 13 years patient received Infanrix vaccine). The outcome of the wrong vaccine administered, drug dose administration interval too long, inappropriate age at vaccine administration and drug dose administration interval too short were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 22-JAN-2025 The medical assistant reported that an Infanrix dose was given unintendedly to a patient who was supposed to receive a Tdap vaccine, which led to wrong vaccine administered. The patient had 2 previous doses of Dtap vaccine and no previous Tdap doses. The patient received a 3rd dose of Infanrix at an inappropriate age, which led to inappropriate age at vaccine administration. The patient received 3rd dose of Infanrix, later than the recommended interval, which led to lengthening of vaccination schedule. The patient received 2nd dose of DTaP earlier than recommended interval, which led to shortening of vaccination schedule. The Vaccine Administration Facility was the same as Primary Reporter.
Age: 55.0
Sex: M
Vaccine: VARZOS
Symptoms: Fatigue, Influenza like illness, Pain, Pain in extremity, Restlessness
Clinical narrative: Sore arm at 3 hours, fatigue at 6 hours, restlessness all night, and full body aches in the following morning, with continued fatigue. Feels like flu
Age: 55.0
Sex: F
Vaccine: HEP
Symptoms: Blood magnesium normal, Computerised tomogram head normal, Computerised tomogram neck normal, Differential white blood cell count, Electrocardiogram abnormal
Clinical narrative: Patient received the Hep B vaccine in the Left Deltoid on 02/19/2025 at 0846 am. Tinnitus-like symptoms started on 02/19/25 at 1530 pm in both ears. Patient self-medicated with ibuprofen the evening of 02/19/25 but experienced little relief. Patient woke up 02/20/25 to worsened symptoms and experienced amplified sensitivity to sound and wind, and heard vibrations when she spoke. Patient experienced difficulty hearing bilaterally, but diminished hearing was worse in the left ear than the right. Patient was seen in the ED on 02/20/25 around 0800 am for worsening symptoms. CT of the head and neck with and without contrast were performed while in the ED. CT results were normal. EKG and blood work were also done. A referral to otolaryngology was made for the patient. Patient is also following up with a  location to have an audiology test performed as of today, 02/21/25.
Age: 55.0
Sex: F
Vaccine: HEP
Symptoms: Full blood count, Hyperacusis, Hypoacusis, Metabolic function test, Scan with contrast normal
Clinical narrative: Patient received the Hep B vaccine in the Left Deltoid on 02/19/2025 at 0846 am. Tinnitus-like symptoms started on 02/19/25 at 1530 pm in both ears. Patient self-medicated with ibuprofen the evening of 02/19/25 but experienced little relief. Patient woke up 02/20/25 to worsened symptoms and experienced amplified sensitivity to sound and wind, and heard vibrations when she spoke. Patient experienced difficulty hearing bilaterally, but diminished hearing was worse in the left ear than the right. Patient was seen in the ED on 02/20/25 around 0800 am for worsening symptoms. CT of the head and neck with and without contrast were performed while in the ED. CT results were normal. EKG and blood work were also done. A referral to otolaryngology was made for the patient. Patient is also following up with a  location to have an audiology test performed as of today, 02/21/25.
Age: 55.0
Sex: F
Vaccine: HEP
Symptoms: Sinus bradycardia, Tinnitus
Clinical narrative: Patient received the Hep B vaccine in the Left Deltoid on 02/19/2025 at 0846 am. Tinnitus-like symptoms started on 02/19/25 at 1530 pm in both ears. Patient self-medicated with ibuprofen the evening of 02/19/25 but experienced little relief. Patient woke up 02/20/25 to worsened symptoms and experienced amplified sensitivity to sound and wind, and heard vibrations when she spoke. Patient experienced difficulty hearing bilaterally, but diminished hearing was worse in the left ear than the right. Patient was seen in the ED on 02/20/25 around 0800 am for worsening symptoms. CT of the head and neck with and without contrast were performed while in the ED. CT results were normal. EKG and blood work were also done. A referral to otolaryngology was made for the patient. Patient is also following up with a  location to have an audiology test performed as of today, 02/21/25.
Age: 75.0
Sex: F
Vaccine: RSV
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient received a second dose of Arexvy (RSV) vaccine in error. First dose received on 02/29/2024. Patient reports no adverse effects.
Age: 78.0
Sex: M
Vaccine: RSV
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient received a second dose of Arexvy (RSV) vaccine in error. First dose received on 02/29/2024. Patient reports no adverse effects.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Pericarditis
Clinical narrative: pericarditis
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Headache, Hypoxia, Respiratory failure, Respiratory syncytial virus infection
Clinical narrative: Age:  54 y.o.  Admit date: 2/14/2025   Discharge date: 2/15/25  Attending Physician at the Time of Discharge: D.O.  Reason for Admission: RSV/COVID respiratory failure   Brief Summary of Hospital Stay: presented hypoxic with wheezing found to have covid/rsv. Treated with decadron/remdesivir with rapid improvement. Ambulated staying 94% on room air. Wanted to dc home, was deemed appropriate and stable for this.  Had headaches with infection that resolved with advil. Return precautions given and r/u recommendations if headaches fail to improve/resolve with resolution of infection given. No red flag symptoms noted.  The patient was discharged in stable condition with improvement of symptoms and appropriate follow up planned.  Discharged to Home.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Wheezing
Clinical narrative: Age:  54 y.o.  Admit date: 2/14/2025   Discharge date: 2/15/25  Attending Physician at the Time of Discharge: D.O.  Reason for Admission: RSV/COVID respiratory failure   Brief Summary of Hospital Stay: presented hypoxic with wheezing found to have covid/rsv. Treated with decadron/remdesivir with rapid improvement. Ambulated staying 94% on room air. Wanted to dc home, was deemed appropriate and stable for this.  Had headaches with infection that resolved with advil. Return precautions given and r/u recommendations if headaches fail to improve/resolve with resolution of infection given. No red flag symptoms noted.  The patient was discharged in stable condition with improvement of symptoms and appropriate follow up planned.  Discharged to Home.
Age: 1.0
Sex: F
Vaccine: HIBV
Symptoms: No adverse event, Product preparation error
Clinical narrative: HIB vaccine was reconstituted with a sterile diluent and not the saline diluent that it is supposed to be mixed with. Patient had no reaction, but vaccine is sub-potent so will have to be re-given
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, COVID-19, Diarrhoea, Hypophagia, Hypotension
Clinical narrative: Age:  64 y.o.  Admit date: 2/14/2025   Discharge date: 2/16/2025   Attending Physician at the Time of Discharge: DO   Primary Care Physician: MD  Reason for Admission: shock   Brief Summary of Hospital Stay: 64 y.o. male with dilated cardiomyopathy (EF 25-30%) presented to ED with viral syndrome and hypotension.  Admitted with viral/hypovolemic shock related to flu/covid.  Hypovolemia from diarrhea and poor intake combined with recent medication increase likely contributing.  Placed on IV fluid support with resolution of hypotension and Acute kidney injury.  He will resume metoprolol alone (decreased dose) and follow with Cardiology to re-initiate CHF treatment.   Problem list: Septic/hypovolemic shock, resolved Influenza/covid              -tamiflu              -tessalon, guaifenesin-dextromethorphan  Dilated Cardiomoypathy (EF 25-30%) without clinical heart failure              -resume toprol at decreased dose -hold Entresto, spironolactone, Jardiance -follow with Cardiology as above, may not need diuretics with no history of overload  Chronic LBBB, history of NSVT               -toprol resumed  Acute kidney injury, resolved   Right renal lesion on ultrasound              -CT recommended by Radiology, follow with PCP, discussed  Although leaving today, this patient will require ongoing assessment and treatment, with adjustments to the plan as appropriate.  Medicine is complicated and unforseen changes in status may occur.  Discharged to Home.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Hypovolaemic shock, Influenza, Renal mass, Septic shock, Ultrasound kidney normal
Clinical narrative: Age:  64 y.o.  Admit date: 2/14/2025   Discharge date: 2/16/2025   Attending Physician at the Time of Discharge: DO   Primary Care Physician: MD  Reason for Admission: shock   Brief Summary of Hospital Stay: 64 y.o. male with dilated cardiomyopathy (EF 25-30%) presented to ED with viral syndrome and hypotension.  Admitted with viral/hypovolemic shock related to flu/covid.  Hypovolemia from diarrhea and poor intake combined with recent medication increase likely contributing.  Placed on IV fluid support with resolution of hypotension and Acute kidney injury.  He will resume metoprolol alone (decreased dose) and follow with Cardiology to re-initiate CHF treatment.   Problem list: Septic/hypovolemic shock, resolved Influenza/covid              -tamiflu              -tessalon, guaifenesin-dextromethorphan  Dilated Cardiomoypathy (EF 25-30%) without clinical heart failure              -resume toprol at decreased dose -hold Entresto, spironolactone, Jardiance -follow with Cardiology as above, may not need diuretics with no history of overload  Chronic LBBB, history of NSVT               -toprol resumed  Acute kidney injury, resolved   Right renal lesion on ultrasound              -CT recommended by Radiology, follow with PCP, discussed  Although leaving today, this patient will require ongoing assessment and treatment, with adjustments to the plan as appropriate.  Medicine is complicated and unforseen changes in status may occur.  Discharged to Home.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Viral infection
Clinical narrative: Age:  64 y.o.  Admit date: 2/14/2025   Discharge date: 2/16/2025   Attending Physician at the Time of Discharge: DO   Primary Care Physician: MD  Reason for Admission: shock   Brief Summary of Hospital Stay: 64 y.o. male with dilated cardiomyopathy (EF 25-30%) presented to ED with viral syndrome and hypotension.  Admitted with viral/hypovolemic shock related to flu/covid.  Hypovolemia from diarrhea and poor intake combined with recent medication increase likely contributing.  Placed on IV fluid support with resolution of hypotension and Acute kidney injury.  He will resume metoprolol alone (decreased dose) and follow with Cardiology to re-initiate CHF treatment.   Problem list: Septic/hypovolemic shock, resolved Influenza/covid              -tamiflu              -tessalon, guaifenesin-dextromethorphan  Dilated Cardiomoypathy (EF 25-30%) without clinical heart failure              -resume toprol at decreased dose -hold Entresto, spironolactone, Jardiance -follow with Cardiology as above, may not need diuretics with no history of overload  Chronic LBBB, history of NSVT               -toprol resumed  Acute kidney injury, resolved   Right renal lesion on ultrasound              -CT recommended by Radiology, follow with PCP, discussed  Although leaving today, this patient will require ongoing assessment and treatment, with adjustments to the plan as appropriate.  Medicine is complicated and unforseen changes in status may occur.  Discharged to Home.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Asthenia, Blood culture negative, COVID-19, Cardiac failure acute
Clinical narrative: BRIEF OVERVIEW: Discharge Provider: MD Primary Care Physician at Discharge:  DO Admission Date: 2/10/2025 Discharge Disposition: Deceased  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute on chronic systolic heart failure (HCC) [I50.23] Gram-negative pneumonia (HCC) [J15.69] Sepsis (HCC) [A41.9] Pneumonia of left lower lobe due to infectious organism [J18.9] COVID [U07.1] Acute on chronic respiratory failure (HCC) [J96.20]  HOSPITAL COURSE: Patient is an 88yr old male with a history of HTN, CAD, CHF, CKK. GERD, ILD, COPD, Pulm HTN, CKD who presented with dyspnea, cough, weakness, found to have COVID and now being managed for Acute Respiratory Failure. He has been worsening in past few days and recently transferred to PCU. This morning he complained of chest pain which seemed to have improved somewhat with nitro, now rated as a 4/10. He however remained very frail, weak and severely debilitated. He said he cannot continue like this and just wants to be done.  Acute Hypoxic Respiratory Failure secondary to COVID vs bacterial superinfection vs ILD exacerbation - He was found to have COVID 02/10/25 with possible bacterial superinfection and has been having worsening respiratory distress requiring HFNC oxygen and transfer to PCU. CTA from 02/16 revealed extensive pulm findings favoring multifocal pneumonia vs nonspecific pneumonitis. Pulm consulted, suspect acute decompensation is likely due to superinfection vs possible ILD exacerbation and abx broadened to vanc and zosyn with continued steroids. Blood cultures no growth so far.  Patient remained very miserable with worsening marked respiratory distress despite being on HFNC oxygen. He expressed that he cannot do this anymore and just wants to "end it".   Hospice consulted and he was evaluated for GIP. He was started on dilaudid as he received minimal relief with morphine. Patient died before start of care for hospice. Time of death 12.21pm
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Computerised tomogram thorax abnormal, Condition aggravated, Cough, Death
Clinical narrative: BRIEF OVERVIEW: Discharge Provider: MD Primary Care Physician at Discharge:  DO Admission Date: 2/10/2025 Discharge Disposition: Deceased  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute on chronic systolic heart failure (HCC) [I50.23] Gram-negative pneumonia (HCC) [J15.69] Sepsis (HCC) [A41.9] Pneumonia of left lower lobe due to infectious organism [J18.9] COVID [U07.1] Acute on chronic respiratory failure (HCC) [J96.20]  HOSPITAL COURSE: Patient is an 88yr old male with a history of HTN, CAD, CHF, CKK. GERD, ILD, COPD, Pulm HTN, CKD who presented with dyspnea, cough, weakness, found to have COVID and now being managed for Acute Respiratory Failure. He has been worsening in past few days and recently transferred to PCU. This morning he complained of chest pain which seemed to have improved somewhat with nitro, now rated as a 4/10. He however remained very frail, weak and severely debilitated. He said he cannot continue like this and just wants to be done.  Acute Hypoxic Respiratory Failure secondary to COVID vs bacterial superinfection vs ILD exacerbation - He was found to have COVID 02/10/25 with possible bacterial superinfection and has been having worsening respiratory distress requiring HFNC oxygen and transfer to PCU. CTA from 02/16 revealed extensive pulm findings favoring multifocal pneumonia vs nonspecific pneumonitis. Pulm consulted, suspect acute decompensation is likely due to superinfection vs possible ILD exacerbation and abx broadened to vanc and zosyn with continued steroids. Blood cultures no growth so far.  Patient remained very miserable with worsening marked respiratory distress despite being on HFNC oxygen. He expressed that he cannot do this anymore and just wants to "end it".   Hospice consulted and he was evaluated for GIP. He was started on dilaudid as he received minimal relief with morphine. Patient died before start of care for hospice. Time of death 12.21pm
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Feeling abnormal, Interstitial lung disease, Left ventricular failure, Pneumonia
Clinical narrative: BRIEF OVERVIEW: Discharge Provider: MD Primary Care Physician at Discharge:  DO Admission Date: 2/10/2025 Discharge Disposition: Deceased  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute on chronic systolic heart failure (HCC) [I50.23] Gram-negative pneumonia (HCC) [J15.69] Sepsis (HCC) [A41.9] Pneumonia of left lower lobe due to infectious organism [J18.9] COVID [U07.1] Acute on chronic respiratory failure (HCC) [J96.20]  HOSPITAL COURSE: Patient is an 88yr old male with a history of HTN, CAD, CHF, CKK. GERD, ILD, COPD, Pulm HTN, CKD who presented with dyspnea, cough, weakness, found to have COVID and now being managed for Acute Respiratory Failure. He has been worsening in past few days and recently transferred to PCU. This morning he complained of chest pain which seemed to have improved somewhat with nitro, now rated as a 4/10. He however remained very frail, weak and severely debilitated. He said he cannot continue like this and just wants to be done.  Acute Hypoxic Respiratory Failure secondary to COVID vs bacterial superinfection vs ILD exacerbation - He was found to have COVID 02/10/25 with possible bacterial superinfection and has been having worsening respiratory distress requiring HFNC oxygen and transfer to PCU. CTA from 02/16 revealed extensive pulm findings favoring multifocal pneumonia vs nonspecific pneumonitis. Pulm consulted, suspect acute decompensation is likely due to superinfection vs possible ILD exacerbation and abx broadened to vanc and zosyn with continued steroids. Blood cultures no growth so far.  Patient remained very miserable with worsening marked respiratory distress despite being on HFNC oxygen. He expressed that he cannot do this anymore and just wants to "end it".   Hospice consulted and he was evaluated for GIP. He was started on dilaudid as he received minimal relief with morphine. Patient died before start of care for hospice. Time of death 12.21pm
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia bacterial, Pneumonitis, Respiratory distress, Scan with contrast abnormal, Sepsis
Clinical narrative: BRIEF OVERVIEW: Discharge Provider: MD Primary Care Physician at Discharge:  DO Admission Date: 2/10/2025 Discharge Disposition: Deceased  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute on chronic systolic heart failure (HCC) [I50.23] Gram-negative pneumonia (HCC) [J15.69] Sepsis (HCC) [A41.9] Pneumonia of left lower lobe due to infectious organism [J18.9] COVID [U07.1] Acute on chronic respiratory failure (HCC) [J96.20]  HOSPITAL COURSE: Patient is an 88yr old male with a history of HTN, CAD, CHF, CKK. GERD, ILD, COPD, Pulm HTN, CKD who presented with dyspnea, cough, weakness, found to have COVID and now being managed for Acute Respiratory Failure. He has been worsening in past few days and recently transferred to PCU. This morning he complained of chest pain which seemed to have improved somewhat with nitro, now rated as a 4/10. He however remained very frail, weak and severely debilitated. He said he cannot continue like this and just wants to be done.  Acute Hypoxic Respiratory Failure secondary to COVID vs bacterial superinfection vs ILD exacerbation - He was found to have COVID 02/10/25 with possible bacterial superinfection and has been having worsening respiratory distress requiring HFNC oxygen and transfer to PCU. CTA from 02/16 revealed extensive pulm findings favoring multifocal pneumonia vs nonspecific pneumonitis. Pulm consulted, suspect acute decompensation is likely due to superinfection vs possible ILD exacerbation and abx broadened to vanc and zosyn with continued steroids. Blood cultures no growth so far.  Patient remained very miserable with worsening marked respiratory distress despite being on HFNC oxygen. He expressed that he cannot do this anymore and just wants to "end it".   Hospice consulted and he was evaluated for GIP. He was started on dilaudid as he received minimal relief with morphine. Patient died before start of care for hospice. Time of death 12.21pm
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Superinfection bacterial
Clinical narrative: BRIEF OVERVIEW: Discharge Provider: MD Primary Care Physician at Discharge:  DO Admission Date: 2/10/2025 Discharge Disposition: Deceased  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute on chronic systolic heart failure (HCC) [I50.23] Gram-negative pneumonia (HCC) [J15.69] Sepsis (HCC) [A41.9] Pneumonia of left lower lobe due to infectious organism [J18.9] COVID [U07.1] Acute on chronic respiratory failure (HCC) [J96.20]  HOSPITAL COURSE: Patient is an 88yr old male with a history of HTN, CAD, CHF, CKK. GERD, ILD, COPD, Pulm HTN, CKD who presented with dyspnea, cough, weakness, found to have COVID and now being managed for Acute Respiratory Failure. He has been worsening in past few days and recently transferred to PCU. This morning he complained of chest pain which seemed to have improved somewhat with nitro, now rated as a 4/10. He however remained very frail, weak and severely debilitated. He said he cannot continue like this and just wants to be done.  Acute Hypoxic Respiratory Failure secondary to COVID vs bacterial superinfection vs ILD exacerbation - He was found to have COVID 02/10/25 with possible bacterial superinfection and has been having worsening respiratory distress requiring HFNC oxygen and transfer to PCU. CTA from 02/16 revealed extensive pulm findings favoring multifocal pneumonia vs nonspecific pneumonitis. Pulm consulted, suspect acute decompensation is likely due to superinfection vs possible ILD exacerbation and abx broadened to vanc and zosyn with continued steroids. Blood cultures no growth so far.  Patient remained very miserable with worsening marked respiratory distress despite being on HFNC oxygen. He expressed that he cannot do this anymore and just wants to "end it".   Hospice consulted and he was evaluated for GIP. He was started on dilaudid as he received minimal relief with morphine. Patient died before start of care for hospice. Time of death 12.21pm
Age: 50.0
Sex: F
Vaccine: HEP
Symptoms: No adverse event
Clinical narrative: Patient did not have any adverse reactions or any outcomes
Age: 75.0
Sex: F
Vaccine: PNC20, RSV, TDAP
Symptoms: Chills, Headache, Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Patient received above vaccines on 02/11/2025. Patient called to report event 02/14. Reported that she had swollen, red and itchy right upper arm below injection site. She did report also the whole next day she had headache, chills and just generally not feeling well.  Upon looking further in her records she did have a similar reaction to the PPSV23 01/15/2019. There was a VAERS filed at that time. She did however have a PCV13 02/23/2017 and did not report a reaction. She did not remember having the PPSV23 reaction in 2019.
Age: 75.0
Sex: F
Vaccine: PNC20, RSV, TDAP
Symptoms: Malaise
Clinical narrative: Patient received above vaccines on 02/11/2025. Patient called to report event 02/14. Reported that she had swollen, red and itchy right upper arm below injection site. She did report also the whole next day she had headache, chills and just generally not feeling well.  Upon looking further in her records she did have a similar reaction to the PPSV23 01/15/2019. There was a VAERS filed at that time. She did however have a PCV13 02/23/2017 and did not report a reaction. She did not remember having the PPSV23 reaction in 2019.
Age: 2.0
Sex: M
Vaccine: HIBV
Symptoms: Product preparation error
Clinical narrative: Administer reconstituted  HIB with  the sterile diluent you would reconstituted with MMR or Varicella instead of the diluent that comes in the box with HIB.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Affective disorder, Ageusia, Anosmia, Anxiety, Chronic spontaneous urticaria
Clinical narrative: I had pain and a burning sensation on my arm. I immediately didn t feel good and went home to lay down.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Depression, Dyspnoea, Fatigue, Injection site pain, Malaise
Clinical narrative: I had pain and a burning sensation on my arm. I immediately didn t feel good and went home to lay down.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: I had pain and a burning sensation on my arm. I immediately didn t feel good and went home to lay down.
Age: 39.0
Sex: M
Vaccine: FLU3
Symptoms: Dizziness, Dyspnoea, Hypoaesthesia, Muscular weakness
Clinical narrative: Shortness of breath, dizziness, muscle weakness, and numbness.
Age: 41.0
Sex: F
Vaccine: YF
Symptoms: Hypoaesthesia, Lumbar puncture normal, Post lumbar puncture syndrome
Clinical narrative: Numbness in Left pinky finger that then spread to the legs.
Age: 0.33
Sex: M
Vaccine: RV5
Symptoms: Abdominal discomfort, Flatulence, Infant irritability
Clinical narrative: Extreme stomach discomfort, fussiness, irritability, extreme gas that lasted 7 days.
Age: 0.5
Sex: M
Vaccine: HIBV
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Child was given a 3rd dose of Pedvax HIB at 6 month appointment.  Child had received pedvax hib at 2 months and 4 months so was not due for another dose at 6 months.
Age: 46.0
Sex: F
Vaccine: TDAP
Symptoms: Incorrect route of product administration, Injection site erythema, Injection site pain, Peripheral swelling, Product administered at inappropriate site
Clinical narrative: Patient was given vaccine on 2/18/2025; it was not administered properly and given in the subcutaneous area of the arm with an intramuscular length needle . She reports injection site has been sore to touch since the day/time of injection, but the pain has increased since it was given. She has had arm pain proximal to the site of injection. Her affected arm is swollen and painful to the touch. The injection site has erythema.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Chills, Fatigue, Headache, Migraine
Clinical narrative: 3 hours after receiving vaccine,  fever, chills, nausea, vomiting,  body aches, lasting 4 days. Have been having hair loss, fatigue, tooth loss, random muscle spasms, migraines, daily headaches, since vaccination continues to present.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Nausea, Pain, Pyrexia, Tooth loss
Clinical narrative: 3 hours after receiving vaccine,  fever, chills, nausea, vomiting,  body aches, lasting 4 days. Have been having hair loss, fatigue, tooth loss, random muscle spasms, migraines, daily headaches, since vaccination continues to present.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: 3 hours after receiving vaccine,  fever, chills, nausea, vomiting,  body aches, lasting 4 days. Have been having hair loss, fatigue, tooth loss, random muscle spasms, migraines, daily headaches, since vaccination continues to present.
Age: 0.5
Sex: M
Vaccine: DTAPHEPBIP, FLU3, HIBV, PNC20
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Child was given a 3rd dose of Pedvax HIB at 6 month appointment.  Child had received pedvax hib at 2 months and 4 months so was not due for another dose at 6 months.
Age: 0.5
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC20
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Child was given a 3rd dose of Pedvax HIB at 6 month appointment.  Child had received PEDVaxHIB at 2 months and 4 months so was not due for another dose at 6 months.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Autoimmune disorder, Cognitive disorder, Herpes zoster, Laboratory test
Clinical narrative: Developed shingles, uveitis in left eye followed by psoriatic arthritis and multiple unexplainable ailments such as generalized rashes, pruritus, muscle pain, weakness, cognitive impairment
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pneumonia, Pruritus, Psoriatic arthropathy, Rash
Clinical narrative: Developed shingles, uveitis in left eye followed by psoriatic arthritis and multiple unexplainable ailments such as generalized rashes, pruritus, muscle pain, weakness, cognitive impairment
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Uveitis
Clinical narrative: Developed shingles, uveitis in left eye followed by psoriatic arthritis and multiple unexplainable ailments such as generalized rashes, pruritus, muscle pain, weakness, cognitive impairment
Age: 1.0
Sex: F
Vaccine: MMRV, VARCEL
Symptoms: Extra dose administered, No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient presented to the clinic for her 1 year well child appt. routine vaccinations were discussed and planned on doing PCV-20, Hep A, MMR, and Varicella. However upon recent logging and balancing we realized this patient was given a MMRV and Varicella at that appt. Patient is under the age of 1 and MMRV is not indicated until age 4 . Patient never had an adverse reaction, parents never called to report any abnormal rashes or symptoms after vaccination was administered. patient never went to ED or had f/u with us to discus any adverse symptoms and reactions
Age: 0.5
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC20
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Child was given a 3rd dose of Pedvax HIB at 6 month appointment.  Child had received PEDVaxHIB at 2 months and 4 months so was not due for another dose at 6 months.
Age: 64.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect dose administered
Clinical narrative: Patient was given the incorrect vaccine. Patient was 64 and was given a high dose flu vaccine.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram abnormal, Pulmonary embolism, Thrombosis, Ultrasound Doppler abnormal
Clinical narrative: Blood clot in left leg and pulmonary embolism in left lung
Age: 19.0
Sex: M
Vaccine: FLU3, VARCEL
Symptoms: Arthralgia, Erythema, Pruritus, Rash
Clinical narrative: Left deltoid, reported left elbow joint pain 30 minutes after vaccine. Then 1 hour after vaccine reported rash. Observed erythema and patient reported mild itch.  Joint pain subsided by this time. Received concurrently with varicella in the left arm.
Age: 14.0
Sex: F
Vaccine: HPV9
Symptoms: Expired product administered
Clinical narrative: Vaccine was expired; 02/14/2025
Age: 56.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Mobility decreased, Pain, X-ray limb
Clinical narrative: Pain, Reduced ROM
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Injection site pain, Injection site swelling
Clinical narrative: erythema, swelling and pain to left arm - vaccine site
Age: 68.0
Sex: F
Vaccine: RSV
Symptoms: Injection site erythema, Injection site mass, Injection site swelling, Injection site warmth
Clinical narrative: Patient described redness, warmth, swelling/knot at injection site
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Appendicitis, Balance disorder, Chest discomfort, Coordination abnormal, Corneal scar
Clinical narrative: I have had a series of symptoms since August 2021: appendicitis, severe headache, vision changes, eye redness, cornea scarring, tinnitus, tremors, TMJ, sleep apnea, muscle weakness, balance and coordination issues, leg pain and numbness, chest tightness, heart palpitations or erratic heart rate.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Heart rate irregular, Hypoaesthesia, Laboratory test, Muscular weakness
Clinical narrative: I have had a series of symptoms since August 2021: appendicitis, severe headache, vision changes, eye redness, cornea scarring, tinnitus, tremors, TMJ, sleep apnea, muscle weakness, balance and coordination issues, leg pain and numbness, chest tightness, heart palpitations or erratic heart rate.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Ocular hyperaemia, Pain in extremity, Palpitations, Sleep apnoea syndrome, Temporomandibular pain and dysfunction syndrome
Clinical narrative: I have had a series of symptoms since August 2021: appendicitis, severe headache, vision changes, eye redness, cornea scarring, tinnitus, tremors, TMJ, sleep apnea, muscle weakness, balance and coordination issues, leg pain and numbness, chest tightness, heart palpitations or erratic heart rate.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus, Tremor, Visual impairment
Clinical narrative: I have had a series of symptoms since August 2021: appendicitis, severe headache, vision changes, eye redness, cornea scarring, tinnitus, tremors, TMJ, sleep apnea, muscle weakness, balance and coordination issues, leg pain and numbness, chest tightness, heart palpitations or erratic heart rate.
Age: 1.83
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Expired product administered
Clinical narrative: After I administered vaccines and I was documenting, I notice that the PENTACEL vaccine was 10 days expired. I did notify my supervisor , and patient pcp . I did call Sanofi Pasteur and spoke with  case number 02422880. and per representative. Vaccine is invalid and will need to be re administered. I called and left message to notify patient.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Rash
Clinical narrative: Noticed rash with small blisters on resident's left chest running down her left armpit. c/o pain on the affected area. Tylenol given  for relief,  MD's recommendation Valacyclovir 1 gm PO TIDx 7 days. Vaccination of Shingrix done on Feb 2/18/2025 on Left Deltoid.
Age: 59.0
Sex: F
Vaccine: RAB
Symptoms: Headache, Vision blurred, Visual impairment, Vitreous floaters
Clinical narrative: Patient reports that on Thursday 2/6/25 developed blurred vision. Describes vision change as blurry/foggy vision when trying to look at a screen or read something, reports occasional floaters/black dots in vision. Symptoms have not changed or worsened since began- reports remained stable. Reports did have headaches this past weekend 2/8 and 2/9. Scheduled appointment with eye doctor 2/14/25. Denies light sensitivity, ocular pain, pain with eye movements, n/v, fever.
Age: 1.0
Sex: F
Vaccine: MMRV, VARCEL
Symptoms: Extra dose administered, Pyrexia, Somnolence
Clinical narrative: The patient was accidentally given two doses of varicella on the same day. The patient presented as very groggy and "out of it" and had a fever on the day of vaccination. The next day, she was back to normal.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy bone marrow abnormal, Blood iron decreased, Fatigue, Haemoglobin decreased, Myelodysplastic syndrome
Clinical narrative: Low Hgb  was fine up until 6 months after vaccine developed extreme fatigue  hgb  dropped for 3 months platelets were ok so primary dr referred to hematologist bone marrow indicated MDS with low iron
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Platelet count normal
Clinical narrative: Low Hgb  was fine up until 6 months after vaccine developed extreme fatigue  hgb  dropped for 3 months platelets were ok so primary dr referred to hematologist bone marrow indicated MDS with low iron
Age: 6.0
Sex: F
Vaccine: VARCEL
Symptoms: Expired product administered
Clinical narrative: Varicella was short dated and mistakenly given past expiration date.
Age: 6.0
Sex: F
Vaccine: VARCEL
Symptoms: Expired product administered
Clinical narrative: Vaccine short dated, mistakenly gave it after expiration.
Age: 7.0
Sex: F
Vaccine: VARCEL
Symptoms: Expired product administered
Clinical narrative: Vaccine short dated, mistakenly gave it after expiration.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram, Dysphagia, Hypoaesthesia, Magnetic resonance imaging, Paraesthesia
Clinical narrative: Numbness and tingling in face and fingers.  It began two months after the second Pfizer shot and became less intense over time, but it still persists now.   About 6 months later, patient began experiencing periodic difficulty swallowing.  This symptom remains, but is unpredictable as to when it will occur.
Age: 12.0
Sex: M
Vaccine: TDAP
Symptoms: Asthenia, Fatigue, Malaise, Nausea, Vomiting
Clinical narrative: had nausea, vomiting, fatigue, and malaise noticed upon waking up at 7am. He continued these symptoms throughout the day, slightly lessening in severity around 4pm. At bedtime he had a slightly elevated temperature at 99.5. Earlier temperature readings were normal (97-98). The next day he was weak but recovering and resumed normal activity with extra rest. His previous vaccines include DTaP (DAPTACEL) on 8/14/19 and 7/27/18.
Age: 4.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: Mom reports child had redness and itching at injection site - mom did not wish for medical advise just wanted the reaction to be documented
Age: 5.0
Sex: F
Vaccine: MMRV
Symptoms: Injection site cellulitis, Injection site erythema, Pyrexia
Clinical narrative: Patient experiencing slight fever, cellulitis erythema at injection site, erythema spread to surrounding area
Age: 0.17
Sex: M
Vaccine: FLU3
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Pt given flu vaccine before being 6 month old.
Age: 1.0
Sex: F
Vaccine: FLU3, HIBV, MMRV, PNC20
Symptoms: Body temperature increased, Eye movement disorder, Febrile convulsion, Hypotonia, Postictal state
Clinical narrative: went limp/eye rolling - suspected febrile seizure, checked out by EMS and taken to ED, lasted less than a minute but post ictal state about 20 minutes
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood thyroid stimulating hormone, C-reactive protein, Chest pain, Electrocardiogram
Clinical narrative: Severe generalized weakness, fatigue, paresthesias, chest inflammation/pain, palpitations
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Full blood count, Inflammation, Metabolic function test, Palpitations
Clinical narrative: Severe generalized weakness, fatigue, paresthesias, chest inflammation/pain, palpitations
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Red blood cell sedimentation rate, Troponin, Vitamin test
Clinical narrative: Severe generalized weakness, fatigue, paresthesias, chest inflammation/pain, palpitations
Age: 52.0
Sex: M
Vaccine: TDAP, VARZOS
Symptoms: Chills, Confusional state, Dizziness, Fatigue, Muscular weakness
Clinical narrative: At 52 years old, I was a man with a strong immune system. I rarely if ever got sick and I didn't have any known allergies. My doctor recommended I get Shingrix.   I did and the side effects started several hours after the shot. That evening I noticed weird skin sensitivity. Then a short while later weakness in my legs, slight confusion and unusual tiredness.  Then I started having severe chills, dizziness, blurred vision and more.   I went to bed and my arm was very sore. It was hard to sleep on that side.  I tossed and turned all night, had awful night sweats. See Continuation Page for more details.  See,
Age: 52.0
Sex: M
Vaccine: TDAP, VARZOS
Symptoms: Night sweats, Pain in extremity, Poor quality sleep, Sensitive skin, Sleep disorder
Clinical narrative: At 52 years old, I was a man with a strong immune system. I rarely if ever got sick and I didn't have any known allergies. My doctor recommended I get Shingrix.   I did and the side effects started several hours after the shot. That evening I noticed weird skin sensitivity. Then a short while later weakness in my legs, slight confusion and unusual tiredness.  Then I started having severe chills, dizziness, blurred vision and more.   I went to bed and my arm was very sore. It was hard to sleep on that side.  I tossed and turned all night, had awful night sweats. See Continuation Page for more details.  See,
Age: 52.0
Sex: M
Vaccine: TDAP, VARZOS
Symptoms: Vision blurred
Clinical narrative: At 52 years old, I was a man with a strong immune system. I rarely if ever got sick and I didn't have any known allergies. My doctor recommended I get Shingrix.   I did and the side effects started several hours after the shot. That evening I noticed weird skin sensitivity. Then a short while later weakness in my legs, slight confusion and unusual tiredness.  Then I started having severe chills, dizziness, blurred vision and more.   I went to bed and my arm was very sore. It was hard to sleep on that side.  I tossed and turned all night, had awful night sweats. See Continuation Page for more details.  See,
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Antinuclear antibody positive, Systemic lupus erythematosus
Clinical narrative: Development of Lupus
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Brain fog, Dizziness, Fatigue, Hypersomnia
Clinical narrative: Brain "fog",  dizziness,  hyper somnia,  chronic fatigue
Age: 0.5
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC20
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Child came in for his 6 month appointment and was not due for a 3rd dose of HIB at this time since his two previous doses of HIB were with the PedvaxHIB.   Child received a dose that was not needed at his appointment.
Age: 0.5
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC20
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Child came in for his 6 month appointment and was not due for a 3rd dose of HIB at this time since his two previous doses of HIB were with the PedvaxHIB.   Child received a dose that was not needed at his appointment.